The French High Authority for Health (HAS) develops national diagnostic and care protocols whose objective is to guarantee the quality and safety of care delivery within the French setting. In the first half of 2020, national diagnostic and care protocols have been developed for the following eighteen topics:
- Glanzmann's thrombasthenia and related platelet pathologies
- 7q11.23 microduplication syndrome
- MECP2 gene duplication syndrome
- Behçet's disease
- Becker's muscular dystrophy
- Trisomy 21
- Child hypersensitivity pneumonitis
- Spinal dysraphism (Spina Bifida) - urological management in adults
- HNF-1β related disease
- Pulmonary arterial hypertension
- Charcot-Marie-Tooth hereditary sensitive motoric neuropathies
- Takayasu arteritis
- Chronic non-infectious uveitis in children and adults
- Allan Herndon-Dudley Syndrome (AHDS) (MCT8 thyroid hormone transporter)
- Non-Vascular Ehlers-Danlos Syndrome (NVEDS)
- Bullous pemphigoid
- AA Amyloidosis
- Generic Polyhandicap
See the report in French here.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.